| Item | Name | Cat. No. | Tag/Conjugates |
| Anti-STEAP1 mAbs [Vandortuzumab Biosimilar] (MABL-5391) | MABL-5391 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-FZD mAbs [Vantictumab Biosimilar] (MABL-5392) | MABL-5392 | ELISA, FACS, Functional assay, in vivo binding | G2, Lambda |
| Anti-ANGPT2;VEGFA mAbs [Vanucizumab Biosimilar] (MABL-5393) | MABL-5393 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Lambda;Kappa |
| Anti-VEGFA mAbs [Varisacumab Biosimilar] (MABL-5394) | MABL-5394 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF7/CD27 mAbs [Varlilumab Biosimilar] (MABL-5395) | MABL-5395 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL5 mAbs [Varokibart Biosimilar] (MABL-5396) | MABL-5396 | ELISA, FACS, Functional assay, in vivo binding | G4, Lambda |
| Anti-ITGA2/CD49B mAbs [Vatelizumab Biosimilar] (MABL-5397) | MABL-5397 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-SARS-CoV-2 Spike RBD mAbs [Vebanvibart Biosimilar] (MABL-5398) | MABL-5398 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Clostridium tetani tetanus toxin (TeNT) mAbs [Vecantoxatug Biosimilar] (MABL-5399) | MABL-5399 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ITGA4B7 mAbs [Vedolizumab Biosimilar] (MABL-5400) | MABL-5400 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ALB;CD40LG/CD154 mAbs [Velaprumig Biosimilar] (MABL-5401) | MABL-5401 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Kappa;Kappa |
| Anti-NT5E/CALJA/CD73 mAbs [Uliledlimab Biosimilar] (MABL-5371) | MABL-5371 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CXCR4/CD184 mAbs [Ulocuplumab Biosimilar] (MABL-5372) | MABL-5372 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-KLRG1 mAbs [Ulviprubart Biosimilar] (MABL-5373) | MABL-5373 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Bet v 1 mAbs [Umesolerbart Biosimilar] (MABL-5374) | MABL-5374 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-HGF mAbs [Umikibart Biosimilar] (MABL-5375) | MABL-5375 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-EGFRvIII;CD3E mAbs [Umizortamig1 Biosimilar] (MABL-5376) | MABL-5376 | ELISA, FACS, Functional assay, in vivo binding | na;G1, Kappa;Kappa |
| Anti-PDL1/CD274;TNFRSF9/CD137/4-1BB mAbs [Umizortamig2 Biosimilar] (MABL-5377) | MABL-5377 | ELISA, FACS, Functional assay, in vivo binding | na;na, Kappa;Kappa |
| Anti-RGMA mAbs [Unasnemab Biosimilar] (MABL-5378) | MABL-5378 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SARS-CoV-2 Spike RBD mAbs [Upanovimab Biosimilar] (MABL-5379) | MABL-5379 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
